Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 5Fatigue 3Breast Neoplasms 3Neoplasms 2Rectal Neoplasms 1Prostatic Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Colorectal Neoplasms 1Colonic Neoplasms 1Asthenia 1Arthritis 1Arthralgia 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × methyl hydroxyethyl cellulose × Clear all
NCT02167932 2018-06-06

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
127 enrolled
Breast

Breast Neoplasms, Motor Activity, Neoplasms

NCT02191982 2017-09-12

S-PACT

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
44 enrolled

Asthenia, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡